DiaMedica Therapeutics Inc (NASDAQ:DMAC)
| 2.64 BATS BZX Real-Time Price As of 2:23pm ET |  +0.10 / +3.94%Today’s Change | 1.27 Today|||52-Week Range 4.75 | +67.08% Year-to-Date |
Latest DMAC News | Press Releases
No recent news for DiaMedica Therapeutics Inc.
Today’s Trading
| Previous close | 2.54 |
| Today’s open | 2.65 |
| Day’s range | 2.60 - 2.65 |
| Volume | 650 |
| Average volume (3 months) | 64,935 |
| Market cap | $97.9M |
Data as of 2:23pm ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | +20.95% |
| Earnings growth (this year) | -17.31% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CARMCarisma Therapeutics... | +0.14 | +5.69% |
| --W World Corp | 0.00 | 0.00% |
| ETONEton Pharmaceuticals... | -0.05 | -1.35% |
| CTMXCytomX Therapeutics ... | +0.03 | +2.13% |
Data as of 3:57pm ET, 12/04/2023
Financials
| Next reporting date | March 26, 2024 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$13.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Minneapolis, Minnesota |
Forecasts
